[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

KALA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,363.92

KALA BIO Insider Trading History Chart

KALA BIO Share Price & Price History

^$5.71

▼ -0.27 (-4.52%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

KALA BIO Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/4/2023	Eric Trachtenberg	Insider	Sell	60	$28.55	$1,713.00	11,495
1/4/2023	Mark T Iwicki	CEO	Sell	198	$28.54	$5,650.92	45,966
10/26/2022	Eric Trachtenberg	Insider	Sell	194	$6.52	$1,264.88	2,030
10/26/2022	Mark T Iwicki	CEO	Sell	561	$6.52	$3,657.72	4,464
6/27/2022	Eric Trachtenberg	Insider	Sell	2,613	$0.37	$966.81	111,203
6/27/2022	Mark T Iwicki	CEO	Sell	7,975	$0.37	$2,950.75	251,183
5/25/2022	Ra Capital Management, L.P.	Major Shareholder	Sell	1,434,509	$0.42	$602,493.78	8,045,299
5/23/2022	Ra Capital Management, L.P.	Major Shareholder	Sell	1,250,000	$0.65	$812,500.00	9,624,613
1/4/2022	Mark T Iwicki	CEO	Sell	9,518	$1.30	$12,373.40
1/4/2022	Mary Reumuth	CFO	Sell	2,850	$1.30	$3,705.00
1/4/2022	Romulus K. Brazzell	Insider	Sell	3,504	$1.30	$4,555.20
10/26/2021	Hongming Chen	Insider	Sell	9,449	$1.80	$17,008.20
10/26/2021	Mark T Iwicki	CEO	Sell	27,598	$1.80	$49,676.40
10/26/2021	Todd Bazemore	COO	Sell	12,544	$1.80	$22,579.20
6/28/2021	Hongming Chen	Insider	Sell	2,452	$5.77	$14,148.04
6/28/2021	Mark T. Iwicki	CEO	Sell	7,586	$5.77	$43,771.22

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for KALA BIO (NASDAQ:KALA)

23.98% of KALA BIO stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

KALA BIO Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/14/2023	Board of Trustees of The Leland Stanford Junior University	21,127	$0.31M	0.0%	+85.7%	0.832%
8/11/2023	BlackRock Inc.	26,312	$0.38M	0.0%	+23.1%	1.036%
8/11/2023	Geode Capital Management LLC	17,765	$0.26M	0.0%	N/A	0.699%
8/9/2023	Dimensional Fund Advisors LP	16,441	$0.24M	0.0%	N/A	0.647%
5/16/2023	Jane Street Group LLC	12,372	$0.19M	0.0%	-52.3%	0.527%
5/12/2023	BlackRock Inc.	21,382	$0.32M	0.0%	+36.1%	1.053%
5/12/2023	Bank of America Corp DE	5,350	$81K	0.0%	-59.7%	0.264%
5/12/2023	UBS Group AG	1,918	$29K	0.0%	+518.7%	0.094%
2/15/2023	Jane Street Group LLC	25,953	$0.99M	0.0%	N/A	1.520%
2/15/2023	Samsara BioCapital LLC	12,024	$0.46M	0.1%	-98.0%	0.704%
2/15/2023	Millennium Management LLC	75,696	$2.89M	0.0%	-86.4%	4.434%
2/15/2023	Morgan Stanley	2,094	$80K	0.0%	-98.0%	0.123%
2/13/2023	Clear Street LLC	49,390	$1.88M	0.0%	N/A	2.888%
2/13/2023	Board of Trustees of The Leland Stanford Junior University	11,379	$0.43M	0.0%	-98.0%	0.665%
2/13/2023	Renaissance Technologies LLC	10,592	$0.40M	0.0%	-97.6%	0.619%
2/13/2023	Geode Capital Management LLC	8,936	$0.34M	0.0%	-98.0%	0.523%
2/10/2023	Bank of America Corp DE	13,284	$0.51M	0.0%	+201.2%	0.777%
2/10/2023	Banque Cantonale Vaudoise	1,508	$58K	0.0%	-98.0%	0.088%
1/31/2023	Knights of Columbus Asset Advisors LLC	2,417	$92K	0.0%	N/A	0.141%
11/15/2022	State Street Corp	114,308	$25K	0.0%	-56.3%	7.530%
11/15/2022	Vanguard Group Inc.	1,187,957	$0.26M	0.0%	-17.9%	78.258%
11/15/2022	BlackRock Inc.	787,252	$0.18M	0.0%	-0.8%	51.793%
11/15/2022	Board of Trustees of The Leland Stanford Junior University	568,940	$0.13M	0.0%	-17.4%	37.430%
11/14/2022	Renaissance Technologies LLC	436,800	$97K	0.0%	+22.8%	28.775%
11/3/2022	Vahanian & Associates Financial Planning Inc.	207,440	$46K	0.2%	+14.4%	14.208%
8/18/2022	Goldman Sachs Group Inc.	243,918	$74K	0.0%	+173.6%	0.333%
8/15/2022	State Street Corp	261,744	$79K	0.0%	-78.6%	0.361%
8/15/2022	Millennium Management LLC	572,189	$0.17M	0.0%	+1,044.4%	0.788%
8/13/2022	Renaissance Technologies LLC	355,600	$0.11M	0.0%	+35.9%	0.490%
8/12/2022	Northern Trust Corp	82,452	$25K	0.0%	-79.5%	0.114%
8/8/2022	Integrated Wealth Concepts LLC	152,121	$46K	0.0%	+49.2%	0.210%
7/27/2022	Vahanian & Associates Financial Planning Inc.	181,384	$54K	0.2%	-68.8%	0.250%
6/7/2022	Bank of America Corp DE	479,948	$0.66M	0.0%	-6.0%	0.661%
5/17/2022	Virtu Financial LLC	140,511	$0.19M	0.0%	+11.3%	0.194%
5/17/2022	Mirabella Financial Services LLP	22,100	$30K	0.0%	N/A	0.030%
5/17/2022	Jane Street Group LLC	119,963	$0.17M	0.0%	+552.8%	0.165%
5/16/2022	Goldman Sachs Group Inc.	89,162	$0.12M	0.0%	-56.2%	0.123%
5/16/2022	State Street Corp	1,224,965	$1.69M	0.0%	+9.7%	1.687%
5/16/2022	UBS Group AG	18,200	$25K	0.0%	-47.6%	0.025%
5/13/2022	Renaissance Technologies LLC	261,700	$0.36M	0.0%	+107.9%	0.360%
5/13/2022	Northern Trust Corp	402,304	$0.56M	0.0%	-10.4%	0.554%
5/13/2022	Vanguard Group Inc.	1,683,389	$2.32M	0.0%	-22.2%	2.319%
5/12/2022	Integrated Wealth Concepts LLC	101,940	$0.14M	0.0%	N/A	0.140%
5/11/2022	GSA Capital Partners LLP	27,185	$38K	0.0%	N/A	0.037%
5/10/2022	MAI Capital Management	72,500	$100K	0.0%	N/A	0.100%
5/9/2022	Csenge Advisory Group	20,924	$29K	0.0%	N/A	0.029%
5/9/2022	Banque Cantonale Vaudoise	75,420	$0.10M	0.0%	+30.8%	0.104%
4/27/2022	Vahanian & Associates Financial Planning Inc.	580,578	$0.80M	1.9%	-44.5%	0.800%
4/19/2022	Graypoint LLC	487,106	$0.67M	0.1%	N/A	0.671%
2/10/2022	Pictet Asset Management SA	641,009	$0.78M	0.0%	+63.5%	0.979%
2/10/2022	Rafferty Asset Management LLC	39,071	$47K	0.0%	+58.9%	0.060%
2/9/2022	BNP Paribas Arbitrage SA	445,901	$0.54M	0.0%	+4,079.0%	0.681%
2/8/2022	Northern Trust Corp	448,896	$0.54M	0.0%	-11.7%	0.685%
2/4/2022	Matisse Capital	41,400	$50K	0.0%	-26.2%	0.063%
2/2/2022	Oppenheimer & Co. Inc.	28,100	$34K	0.0%	-31.5%	0.043%
1/28/2022	Vahanian & Associates Financial Planning Inc.	1,046,484	$1.27M	1.0%	N/A	1.598%
12/10/2021	Towercrest Capital Management	122,500	$0.32M	0.1%	N/A	0.187%
11/16/2021	Caxton Corp	1,727,751	$4.53M	3.7%	+1.3%	2.659%
11/15/2021	GSA Capital Partners LLP	25,375	$66K	0.0%	N/A	0.039%
11/12/2021	Renaissance Technologies LLC	166,100	$0.44M	0.0%	N/A	0.256%
11/12/2021	Jump Financial LLC	43,500	$0.11M	0.0%	N/A	0.067%
11/12/2021	Macquarie Group Ltd.	19,498	$51K	0.0%	N/A	0.030%
11/12/2021	Oppenheimer & Co. Inc.	41,000	$0.11M	0.0%	+33.6%	0.063%
11/12/2021	Geode Capital Management LLC	933,242	$2.45M	0.0%	+23.9%	1.436%
11/10/2021	Goldman Sachs Group Inc.	154,957	$0.41M	0.0%	-3.6%	0.239%
11/10/2021	Rafferty Asset Management LLC	24,592	$64K	0.0%	N/A	0.038%
11/9/2021	Barclays PLC	34,053	$88K	0.0%	+43.3%	0.052%
11/9/2021	BlackRock Inc.	3,664,849	$9.60M	0.0%	-1.5%	5.641%
11/8/2021	State Board of Administration of Florida Retirement System	83,483	$0.22M	0.0%	+354.6%	0.128%
11/4/2021	Deutsche Bank AG	29,727	$78K	0.0%	-91.0%	0.046%
11/1/2021	SG Americas Securities LLC	25,373	$66K	0.0%	N/A	0.039%
10/27/2021	Newbridge Financial Services Group Inc.	14,216	$37K	0.0%	N/A	0.022%
10/21/2021	Virginia Retirement Systems ET AL	25,000	$66K	0.0%	N/A	0.038%
10/20/2021	Csenge Advisory Group	19,250	$53K	0.0%	N/A	0.030%
10/19/2021	Greenwich Wealth Management LLC	42,996	$0.11M	0.0%	+40.5%	0.066%
10/8/2021	Wedbush Securities Inc.	31,376	$82K	0.0%	-42.8%	0.048%
9/3/2021	Parametric Portfolio Associates LLC	175,118	$0.93M	0.0%	+22.5%	0.270%
8/17/2021	Maverick Capital Ltd.	81,664	$0.43M	0.0%	N/A	0.126%
8/17/2021	Price T Rowe Associates Inc. MD	56,757	$0.30M	0.0%	+31.1%	0.087%
8/17/2021	Caxton Corp	1,704,849	$9.04M	6.2%	+19.2%	2.624%
8/16/2021	UBS Asset Management Americas Inc.	45,694	$0.24M	0.0%	+117.6%	0.070%
8/16/2021	Cubist Systematic Strategies LLC	44,169	$0.23M	0.0%	-65.0%	0.068%
8/16/2021	California State Teachers Retirement System	66,592	$0.35M	0.0%	+11.6%	0.102%
8/16/2021	Tudor Investment Corp Et Al	11,912	$63K	0.0%	N/A	0.018%
8/16/2021	Charles Schwab Investment Management Inc.	118,978	$0.63M	0.0%	+15.8%	0.183%
8/16/2021	State Street Corp	822,294	$4.36M	0.0%	+17.5%	1.266%
8/16/2021	Nuveen Asset Management LLC	181,653	$0.96M	0.0%	-36.2%	0.280%
8/16/2021	Goldman Sachs Group Inc.	160,759	$0.85M	0.0%	+82.0%	0.247%
8/13/2021	Northern Trust Corp	490,088	$2.60M	0.0%	+9.0%	0.754%
8/13/2021	Algert Global LLC	72,490	$0.38M	0.1%	+421.5%	0.112%
8/13/2021	Ensign Peak Advisors Inc	46,091	$0.24M	0.0%	-61.7%	0.071%
8/13/2021	Geode Capital Management LLC	753,298	$3.99M	0.0%	+10.4%	1.159%
8/13/2021	Vanguard Group Inc.	2,204,009	$11.68M	0.0%	+5.2%	3.392%
8/13/2021	ProShare Advisors LLC	24,158	$0.13M	0.0%	+26.6%	0.037%
8/12/2021	Dimensional Fund Advisors LP	399,464	$2.12M	0.0%	-14.4%	0.615%
8/12/2021	The Manufacturers Life Insurance Company	30,389	$0.16M	0.0%	+21.9%	0.047%
8/12/2021	Knights of Columbus Asset Advisors LLC	236,257	$1.25M	0.1%	+18.2%	0.364%
8/12/2021	Bridgefront Capital LLC	47,569	$0.25M	0.1%	-7.4%	0.073%
8/11/2021	Taylor Wealth Management Partners	42,990	$0.23M	0.1%	+13.8%	0.066%
8/11/2021	Bank of New York Mellon Corp	179,289	$0.95M	0.0%	+4.9%	0.276%

Data available starting January 2016

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Today's Range

Now: $5.71

$5.60

$6.20

50 Day Range

MA: $7.47

$5.28

$10.69

52 Week Range

Now: $5.71

$3.54

$56.72

Volume

37,274 shs

Average Volume

385,151 shs

Market Capitalization

$15.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of KALA BIO?: KALA BIO's top insider investors include:
Ra Capital Management, LP (Major Shareholder)
Mark T Iwicki (CEO)
Eric Trachtenberg (Insider)
Mary Reumuth (CFO)
Romulus K Brazzell (Insider)
Learn More about top insider investors at KALA BIO.
Who are the major institutional investors of KALA BIO?: KALA BIO's top institutional shareholders include:
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of KALA BIO stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

KALA Insider Trading

KALA BIO Insider Trading History Chart

KALA BIO Share Price & Price History

KALA BIO Insider Trading History

SEC Filings (Institutional Ownership Changes) for KALA BIO (NASDAQ:KALA)

Institutional Buying and Selling by Quarter

KALA BIO Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of KALA BIO?

Who are the major institutional investors of KALA BIO?